Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 649-654

  Lee, Jong Soo ^a   Lee, Jun Han ^a   Poo, Haryoung ^b   Kim, Mi Suk ^c   Lee, Seung Hoon ^c   Sung, Moon Hee ^a,d   Kim, Chul Joong ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c National Cancer Center   (South Korea)

^d Kookmin University   (South Korea)

Author keywords

Angiostatin; Glioblastoma; p53; PTEN; rSFV

Indexed keywords

ANGIOSTATIN; HYBRID PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING; FLOW CYTOMETRY; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; NICK END LABELING; NUDE MOUSE; PATHOLOGY; SEMLIKI FOREST ALPHAVIRUS; TUMOR CELL LINE; WESTERN BLOTTING;

ANGIOSTATINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, NUDE; PTEN PHOSPHOHYDROLASE; RECOMBINANT FUSION PROTEINS; SEMLIKI FOREST VIRUS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33645218595     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.649     Document Type: Article

References (30)

1. James CD and Olson JJ: Molecular genetics and molecular biology advances in brain tumors. Curr Opin Oncol 8: 188-195, 1996.
2. Louis DN and Gusella JF: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415, 1995.
3. Westermark B and Nister M: Molecular genetics of human glioma. Curr Opin Oncol 7: 220-225, 1995.
4. Berglund P, Tubulekas I and Liljestrom P: Alphaviruses as vectors for gene delivery. Trends Biotech 14: 130-134, 1995.
5. Frolov I, Hoffman TA, Pragai BM, et al: Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci USA 93: 11371-11377, 1996.
6. Bates S and Vousden KH: p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6: 12-18, 1996. (Pubitemid 26059045)
7. Hartwell LH and Kastan MB: Cell cycle control and cancer. Science 266: 1821-1828, 1994.
8. Quazilbash MH, Xiao X, Seth P, et al: Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53. Gene Ther 4: 675-682, 1997.
9. Roth JA, Nguyen D, Lawrence DD, et al: Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991, 1996.
10. Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
11. Di Cristofano A and Pandolfi PP: The multiple roles of PTEN in tumor suppression. Cell 100: 387-390, 2000.
12. 1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: 15406-15411, 1998.
13. Cheney IW, Johnson DE, Vaillancourt MT, et al: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58: 2331-2334, 1998.
14. Minaguchi T, Mori T, Kanamori Y, et al: Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res 59: 6063-6067, 1999.
15. Griscelli F, Li H, Bennaceur-Griscelli A, et al: Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 95: 6367-6372, 1998.
16. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
17. Lucas R, Holmgren L, Garcia I, et al: Multiple form of angiostatin induces apoptosis in endothelial cells. Blood 92: 4730-4741, 1998.
18. Griscelli F, Li H, Cheong C, et al: Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA 97: 6698-6703, 2000.
19. Kirsch M, Strasser J, Allende R, et al: Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 58: 4654-4659, 1998.
20. Yokoyama Y, Dhanabal M, Griffioen AW, et al: Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res 60: 2190-2196, 2000.
21. Hinds PW and Weinberg RA: Tumor suppressor genes. Curr Opin Genet Dev 4: 135-141, 1994.
22. Sandig BV, Brand K, Herwig S, et al: p16 and p53 genes transferred with the help of adenovirus to induce apoptotic tumor cell death. Ugeskr Laeger 159: 6825-6830, 1997. (Pubitemid 127513517)
23. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 3: 313-319, 1997.
24. Wahlfors JJ, Zullo SA, Loimas S, et al: Evalution of recombinant alphaviruses as vectors in gene therapy. Gene Ther 7: 472-480, 2000.
25. Murphy AM, Morris-Downes MM, Sheahan BJ, et al: Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Ther 7: 1477-1482, 2000.
26. Seth P, Brinkmann U, Schwartz GN, et al: Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and born marrow purging. Cancer Res 56: 1346-1351, 1996.
27. Swisher SG, Roth JA, Nemunaitis J, et al: Adenovirus-mediated p53 gene transfer in advanced non-small cell lung cancer. J Natl Cancer Inst 91: 763-771, 1999.
28. INK4A expression on cell cycle arrest is determined by endogenous p16 and Rb status in human cancer cells. Oncogene 6: 265-272, 1998.
29. Tanaka T, Cao Y, Folkman J and Fine HA: Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res 58: 3362-3369, 1998.
30. Patel SD, Tran AC, Ge Y, et al: The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene. Mol Ther 2: 161-169, 2000.